MPS and SB are co-inventors of intellectual property licensed by Duke University to Clinetic, Inc. and Cohere-Med, Inc. MPS and SB hold equity in Clinetic, Inc. MPS and SB receive funding from the Gordon and Betty Moore Foundation, Patrick J McGovern Foundation, and NIH. KS's institution receives grant funding from Teva Pharmaceuticals and Blue Cross Blue Shield of Michigan for unrelated work, and KS serves on an advisory board for Flatiron Health. XL receives funding from the Wellcome Trust, the National Institute of Health Research/ NHSX/Health Foundation, the Alan Turing Institute, the MHRA, and NICE.